Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity

Clinical trial NCT01863459 · COMPLETED

Trial details

NCT number

NCT01863459

Sponsor

Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2013-04-01

Primary completion

2017-03-01

Enrollment

42

View on ClinicalTrials.gov